A
Accustem Sciences Ltd
OTC:ACUT
Accustem Sciences Ltd
OTC:ACUT
Price:
0.32
USD
Market Closed
Market Cap:
$5.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Twentyfirst Century Management Services Ltd
NSE:21STCENMGM
|
IN |
|
Swatch Group AG
OTC:SWGAY
|
CH |
|
Novo Nordisk A/S
CSE:NOVO B
|
DK |
Accustem Sciences Ltd
Cash from Operating Activities
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Accustem Sciences Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Accustem Sciences Ltd
OTC:ACUT
|
Cash from Operating Activities
-$664.1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Operating Activities
$19B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
10%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Operating Activities
$10B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Operating Activities
$10B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Operating Activities
$3.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Operating Activities
$5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
|
No Stocks Found
Accustem Sciences Ltd
Glance View
The company is headquartered in New York City, New York. The company went IPO on 2021-07-09.
ACUT
Intrinsic Value
Not Available
A
See Also
What is Accustem Sciences Ltd's Cash from Operating Activities?
Cash from Operating Activities
-664.1k
USD
-664.1k
USD
Based on the financial report for Dec 31, 2024, Accustem Sciences Ltd's Cash from Operating Activities amounts to -664.1k USD.
What is Accustem Sciences Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
59%
59%
Over the last year, the Cash from Operating Activities growth was 59%.
